Moreover, as they can directly and indirectly modulate the expression of programmed cell death 1 (PD-1) and PD-ligand (L) 1 in the tumor environment, targeting of M2-like TAM has been proposed to represent an effective approach in TNBC to modulate the activity of immune checkpoint inhibitors [21]. Here, PDCD1 is linked to neoplasm.